Artificial Intelligence (AI) in Healthcare Market By Type, Applications, Growth Drivers, Trends, Demand And Global Forecast To 2023

Artificial Intelligence in Healthcare Market Analysis

As per a report published by Market Research Future (MRFR), the global healthcare artificial intelligence market is likely to capture an impressive CAGR of 51.9% over the forecast period 2018 to 2023. Additionally, the potential of artificial intelligence has dramatically transformed the healthcare market since the past few decades. Technological progress, coupled with the associated algorithm is driving the market growth to a considerable extent.

Artificial intelligence (AI) finds wide application in healthcare research activities. It helps in identifying chronic disorders, managing them with utmost importance, discovering drugs, and delivering required health services. AI systems and applications offer new avenues and efficiencies which enable healthcare researchers and professionals to enhance their performance and improve the lives of the patients. The algorithms used in Artificial intelligence helps practitioners in analyzing complicated research information. The potential of the algorithm to interpret the given data in a meaningful way aids in the manufacturing of precision drugs, predicting the outcome of a medical scenario, and drug discovery.

Artificial Intelligence in Healthcare Market Segmentation

AI in Healthcare Market Statistics has been segmented based on application, component, end user, and technology.

By application, the healthcare artificial intelligence market has been segmented into robot-assisted surgery, virtual nursing assistant, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis.

By component, the healthcare artificial intelligence market has been segmented into services, software, and hardware.

By end user, the healthcare artificial intelligence market has been segmented into diagnostic centers & hospital, biotechnology & pharmaceutical companies, and research & academic laboratories.

By technology, the healthcare artificial intelligence market has been segmented into natural language processing, querying method, and machine learning.

Artificial Intelligence in Healthcare Market Regional Analysis

Based on region, the global healthcare AI market has been segmented into Asia-Pacific, Europe, the Americas, and the Middle East and Africa. The Americas held the largest share of the global healthcare AI market. The region is expected to lead the global healthcare AI market in the upcoming years. The growth of the Americas can be attributed to the rapidly expanding biotechnology sector, well-developed healthcare infrastructure, and the progressive instances of robotic surgery. The Massachusetts Biotechnology Council report 2016 states that the prevalence of biotechnology companies has crossed 250 within Cambridge and Boston. It has also revealed that in 2018, biotech job opportunities witnessed a sharp increase by 6.7% as compared to 2015. In 2017, Europe held the second-largest share in the global healthcare AI market. The growth in this market is owing to the wide-ranging research & development activities conducted in the healthcare domain. 

The rapid adoption of technology, along with the surging level of investments by the government also plays a major role in propelling the market growth in this region. A report published by the Nuffield Council on Bioethics stated that in 2018, a deal of USD 1.2 billion was signed between the industry players and the UK government. The deal included an investment of USD 371 million in AI research. Asia-Pacific is projected to record a healthy CAGR over the forecast period. The development in this region is mostly due to the growing demand for therapeutic cure of chronic ailments. Besides, the rapidly evolving healthcare sector in this region acts as a significant factor for driving the healthcare AI market. The Middle East and Africa market is estimated to witness slow development owing to lack of awareness, strict government regulations, and less exposure to healthcare services.

Browse Complete Report @

Artificial Intelligence in Healthcare Market Competitive Landscape

The global healthcare AI market is marked with the presence of key players such as Koninklijke Philips N.V., IBM Corporation, Intel Corporation, NVIDIA Corporation, Deep Genomics, Inc., Microsoft Corporation, Siemens Healthineers GmbH, General Electric Company, CloudMedx Inc., Google, Inc., General Vision, Inc., Johnson & Johnson, Medtronic Plc., and Stryker Corporation.

Agricultural Biotechnology Market Competition, Gross Margin Study, Latest Innovations, Research, Segment, Growth Prediction, Industry Trends, Upcoming Trends And Opportunity Assessment

Agricultural Biotechnology Market Analysis: 

Global agricultural biotechnology market size is showing positive signs of making progress from a valuation of USD 27778.64 million in 2018 with a CAGR of 10.10% during the forecast period of 2019-2024. Market Research Future (MRFR) declared that the growing demand for better crop yield, increased inclusion of advanced technologies, and a rise in investment in the sector would dominate the global agricultural biotechnology market. 

The global market would get solid backing from various agrarian countries from the developing parts of the world. However, poor financial states can be a big distraction for such markets.   

Agricultural Biotechnology Market Segmentation: 

The global report on the agricultural biotechnology market has been studied by MRFR analysts to understand how the market is creating a strong base for itself. This study includes segments like crop type, application, and technique.  

By crop type, the report on the agricultural biotechnology market can be segmented into maize, cotton, soybean, and others. The soybean sector is getting strong traction from its inclusion in US-China deals. Its nutritional value is substantially high, which is impacting the global market intake.  

By application, the report on the agricultural biotechnology market includes stacked traits, insect tolerance, herbicide tolerance, and others. The insect tolerance segment is getting traction due to the rise in demand for better crop yields.  

By basis of technique, the report on the agricultural biotechnology market has been segmented into molecular diagnostics, molecular breeding, genetic engineering, and tissue culture. The genetic engineering segment would see a hike in its intake as several market players are increasing their investment to spur growth.  

Agricultural Biotechnology Market Regional Analysis: 

North America is making a strong move forward by creating opportunities for easier inclusion of latest technologies, better investment facilities, and others. The regional demand for top-class production, myriad types of crops, and crops for biofuel is expected to boost the regional market growth rate. The US and Canada are making significant progress in the sector. In Latin America, this growth is getting backed by Brazil and Argentina. But the financial setting is not well-developed like the North American region.  

In Europe, the market would gain from rising investment for technologies and high spending for the research and development sector. In Asia Pacific region, agrarian countries would create a strong scope for the market to expand substantially.  

Agricultural Biotechnology Market Competitive Landscape: 

The global market for agricultural biotechnology is benefiting from the rising demand for a higher level of crop yield and reduction in labor. Various companies are working to establish these factors. These companies are Thermo Fisher Scientific (US), Arcadia Biosciences (US)., Biocentury Transgene Co., Ltd (China), Vilmorin & Cie (France), Dr. Chip Biotech Inc. (Taiwan), Evogene Ltd (Israel), Bayer AG (Germany), LGC Biosearch Technologies (US), Corteva Agriscience (US), Eurofins Scientific (Luxembourg), and Yield10 Bioscience, Inc. (US). MRFR enlisted several strategic tools implemented by these companies to understand the growth trajectory. These factors are mainly mergers, collaborations, better innovations, increased spending for research and development projects, marketing strategies, and other routes. These are expected to ease the process of understanding the market and further development of profit-making policies.   

Browse Complete Report @

Agricultural Biotechnology Industry News: 

In March 2020, the US-China trade deal revealed promises made by the Chinese government in terms of agricultural biotechnology. China said that they would streamline their technological side to increase the acceptance process of various technologies provided by their US counterpart. The US govt lauded this move as this can ensure revenues reaching billions of dollars. The faster-streamlining procedure will also boost the Chinese agricultural sector. 

Bacterial Cell Culture Market Analysis, Size, Share And Overview

Bacterial Cell Culture Market – Overview

The importance of advanced antibiotics is stimulating demand for the bacterial cell culture market. Reports that evaluate the life sciences industry have been made accessible by Market Research Future, which creates reports on several industry verticals that review the market development and prospects. The Bacterial Cell Culture Market Trends is projected to be spurred by an accelerated CAGR in the forecast period.

The augmented use of bacterial cell culture market in pharmaceuticals and cosmetics, among others, is expected to enhance the market growth. The amplified stress on life science research is expected to encourage the bacterial cell culture market. Furthermore, the popularity of alternative fuels due to the renewable energy movement is projected to spur the market for bacterial cell culture in the approaching period.

Bacterial Cell Culture Market Segmental Analysis

The segmental assessment of the bacterial cell culture market is segmented on the basis of consumable, instruments, application, and end-user.  Based on the consumables, the bacterial cell culture market is segmented into reagents, media, and others. The instruments segment in the market is segmented into centrifuge, incubator, spectrophotomete, and biosafety cabinet.  By application, the bacterial cell culture market segment consists of water testing, food testing, animal feed testing, agricultural research, bioenergy production, and others. Based on the end-users, the bacterial cell culture market is segmented into the pharmaceutical industry, diagnostic centers, hospital & clinics, biotechnology companies, and academic & research institutes. Based on the region, the bacterial cell culture market is segmented into the Middle East, Americas, Europe, Africa, and the Asia Pacific.

Bacterial Cell Culture Market Regional Analysis    

The evaluation of the regions in the bacterial cell culture market comprises of the Middle East, Americas, Europe, Africa, and the Asia Pacific. The global bacterial cell culture market is governed by the North American region owing to the rising biopharmaceutical and life science industries in this region. It is projected that the European region is the next major segment in the bacterial cell culture market. The intensifying food and animal feed testing is steering the growth of the market. The Asia Pacific region is expected to witness growth in the bacterial cell culture market due to the mounting number research institutes, increasing demand for antibiotics, and growing need for food testing. Japan, China, and India are significant market companies in this region and is anticipated to be the major market for the bacterial cell culture. India, which is an agricultural country and has a high use of Plant growth-promoting bacteria (PGPB) to avert crops from abiotic stress, and diseases, is driving the market evolution in this region.


Bacterial Cell Culture Market Competitive Analysis

The changes in the income levels globally are contributing to the growth of the market. The rise in individual discretionary spending is anticipated to lead to the progress of the market. The enhancement of the distribution channels is projected to motivate market growth relatively. The conducive nature of the monetary and fiscal policies is likely to lead to solid growth in the market. Moreover, the rise in International transactions is anticipated to bolster the expansion of the market considerably. The disequilibrium noticed in the forces that are backing the growth of the market is expected to lead to a relatively slow pace of the growth. The global economies are reacting to the market forces by implementing favorable policies and cutbacks so as prevent a slowdown in the progress of the market. The positive effect induced by governments in the development of the market is expected to guide the market towards sound progress in the coming years.

The eminent contenders in the bacterial cell culture Market are bioMérieux S.A., Bio-Rad Laboratories, Inc., Eiken Chemical Co, Ltd., EMD (Merck) Millipore, ScienCell Research Laboratories, Inc., Becton, Dickinson and Company,Hi-Media Laboratories Pvt. Ltd., Neogen Corporation, Scharlab S.L., Thermo Fisher Scientific, Inc., and Culture Media & Supplies, Inc.

Medical Waste Management Equipment Market 2020: Industry Overview, Driving Factors, Segments, Regional Analysis And Competitive Analysis – Forecast To 2025

Medical Waste Management Equipment Market Overview

Activities related to disposing of the waste products from hospitals and running the procedure to make them non-toxic are called medical waste management. Equipment useful for this is called medical waste management equipment. A new research on the global Medical Waste Management Equipment Market Report, published by Market Research Future (MRFR), marks that this market could witness growth between 2016 and 2022.

The largest market driver for the global medical waste management equipment market growth is the increasing number of hospitals facilities. Research in the field of chemicals, pharmaceutical, and life sciences is also creating a large market for medical waste management. Wastes that cause dioxin pollution and mercury pollution are hazardous to the environment, and their disposal is among top priorities for reducing pollution. For environmental safety, the treatment and proper disposal of medical waste have been made compulsory by the government of many countries. Medical waste management is also necessary for keeping the hospital premises clean as dirty surroundings can cause patients as well as medical staff to suffer from new diseases. The growing chemical industry is also driving the market for medical waste management and thus, the requirement for the medical waste management equipment.

Medical Waste Management Equipment Market Segmentation

The global medical waste management equipment market segmentation encompasses types of waste, type of product, method of treatment, and site of treatment. MRFR’s take on the market surveys various facets of the market in-depth.    

By types of waste, this market has been segmented into infectious waste, non-infectious/hazardous waste, medical disposables, and radioactive waste. Based on the method of treatment, the market has been segmented into the disposal, mechanical/chemical disinfection, irradiation, recycling, and others.

Regarding the type of product, the market has been segmented into the autoclave, microwave, sterilization equipment, and others. Autoclave segment holds the largest market share.

In the context of the site of treatment, the market has been segmented into onsite and off-site. Onsite treatment is when the garbage is treated where it has been found. Off-site treatment is about garbage being collected and being taken for treatment.

Medical Waste Management Equipment Market Regional Segmentation

A geographical outlining of the global medical waste management equipment market covers North America, Europe, Asia Pacific, and the Middle East & Africa (MEA).

In North America, the USA can hold the top spot due to steady growth prospects of the medical research sector here (and the whole of North America in general). Other factors push the market growth in North America include consistent growth of the healthcare sector, steady increase in the number of hospitals, government-supported medical waste management initiatives, and lastly, importance of protecting citizens and biosphere from the adverse effects of medical waste.

During the forecast period, Europe can remain a leading regional market due to the strong support given by governments in European countries to the initiatives to make medical waste nontoxic and harmless to the environment. The strongest economies in this region that can become strong markets are France, Germany, and the UK.

During the forecast period, the Asia Pacific is likely to become the fastest-growing regional market due to the rapid growth of the healthcare sector in developing countries like China, Indonesia, India, Japan, Malaysia, Philippines, South Korea, and Taiwan. The growing number of hospitals in these countries can drive market in the Asia Pacific region.

In the MEA region, the market is limited due to limited availability of medical facilities, lack of awareness, lack of sanitation as well as hygiene.


Medical Waste Management Equipment Market Key Players

Big players in the global medical waste management equipment market include Clean Harbors (USA), MedPro Medical Waste Disposal (USA), Republic Services Inc. (USA), Stericycle Inc. (USA), and Waste Management Inc. (USA).

Healthcare Biometrics Market 2020 Review, Key Players Profile, Statistics, Trends, Size, Segments, Competitors Strategy, Regional Analysis And Growth By Forecast To 2022

Healthcare Biometrics Market Insights

Digitization, t echnological enablement, and automation like factors have created deep penetration in the industries and are rapidly influencing the healthcare sector. The adoption of the latest technologies is driven by parameters such as efficiency optimization, cost control, and meet the long-term objectives. Market Research Future anticipated that the global healthcare biometrics market share will touch the mark of USD 5.6 billion at the CAGR of 22.3% during the forecast period, 2016-2022.

Biometrics technology is swiftly venturing in the healthcare sector specifically to retrieve the medical data of patients through fingerprint scanners, palm vein readers, facial recognition solutions, iris scanners, or mobile link authentication for smooth treatment and transparent transaction.

Some of the drivers driving the growth for the global healthcare biometrics market are the surge in demand for high-tech and authentic data tracking technologies and the rise in healthcare service awareness with favorable reimbursement policies. Growing patient pool and rise in healthcare expenditure is marking a radical shift towards digitization owing to the efficient and precise results. However, these trends are expected to help the global healthcare biometrics market during the forecast period.

Healthcare Biometrics Market Segmentation

The global healthcare biometrics market is broadly segmented on the basis of application, technology, and end-users.

The technology segment of the global healthcare biometrics market is bifurcated into face recognition, fingerprint recognition, palm geometry recognition, iris recognition, vein recognition, and others.

The application, the global healthcare biometrics market, is classified into medical record management, patient identification, patient monitoring, data security, and others. The patient monitoring segment is anticipated to spur swiftly due to escalating demand for superior patient care service.

The global healthcare biometrics market is also diversified into the end-user, such as research laboratories, hospitals, healthcare institutes, and others. The major contributor to the global market around the globe is the hospital segment owing increased adoption of biometric systems.

Healthcare Biometrics Market Regional Insights

Growing demand for sophisticated healthcare facilities and regulatory needs are some of the factors encouraging the growth of global market growth. North America is holding a majority of the market share owing to well-established digital sector and constant innovation driven by high acceptance rate. The insurance sector is also backing the growth trend of the market. Due to dominance in various service offerings such as medical record management, patient identification, patient monitoring, data security, and authentication solutions, the US lead the global market.

The European healthcare biometrics market is set to emerge as the most lucrative market as various industry giants are eyeing the region for expansion to increase production capacity. The rise in disposable income and booming economies with end-users looking for solutions to make the healthcare monitoring simple are some of the key factors driving the growth of the global market.

The Asia Pacific market is predicted see a swift growth owing to the growing demand for healthcare services supported by growing patient population. The scope of expansion in various untapped areas in the region might create worthwhile opportunities in the market and encourage growth.


Healthcare Biometrics Market Players

The leading players in the global healthcare biometrics market are more inclined towards developing a well-defined and transparent treatment and diagnostic process to mark their position highest in the graph. These leading players include NEC Corporation, Crossmatch Technologies Inc., Bio-Key International, Morpho (A Subsidiary of Safran SA), Integrated Biometrics, Imprivata Inc., Fujitsu Limited, 3M Cogent Inc.

Nonclinical Homecare Software Market 2023 – Size, Share, Growth, Statistics, Competitor Landscape, Key Players Analysis, Trends, Overview, Competitors Strategy, Regional Analysis And Growth Foresight

Nonclinical Homecare Software Market Overview:

The market report for nonclinical homecare software declares that the growth possibilities in the coming years would touch a valuation of USD 6,408.8 million by 2023 with a growth rate of 13.5% CAGR in between 2016 to 2023, which Market Research Future (MRFR) would assess as a forecast period. 

Homecare software is a specifically-designed software that can be used to operate in the homecare industry. The software has been developed especially for elderly people and people with some sort of disability. These people, they find managing their daily routine quite cumbersome and to support them, a lot of homecare agencies are showing interest. The global Nonclinical Homecare Software Market Trends is witnessing a rise in the registering of chronic diseases owing to which people are now putting up requirements for such assistance. However, the market can find distraction in the shape of high cost of various software, data security concerns, and lack of skilled professionals who can provide the support. Such instances can hold back the market significantly in the coming days.

Nonclinical Homecare Software Market Segmentation:

The global market report for the nonclinical homecare software can be segmented by application, and end users. These segments are infused with information regarding factors that can impact growth and initiate transformation in the shaping process for the global market.

By application, the global market report for nonclinical home care software can be segmented into telehealth systems, nonclinical health management systems, agency systems, and others. The agency system includes invoicing & scheduling, billing, personnel management system & payroll, homecare accounting system, and others. The telehealth systems segment would record the fastest CAGR of CAGR of 13.9% during 2016-2023.

By end user, the market report on the nonclinical home care software includes rehabilitation centers/therapy centers, hospice care, private home care agency, and others. The market is supposed to profit from private home care agencies for their increased promotion of various proceedings.

Nonclinical Homecare Software Market Regional Segmentation:

The way the global market is making progress, the Americas can be taken into account as major traction provider. The dominance of America would be considerable as the region would benefit from a significant patient population, better healthcare spending, and a well-structured healthcare sector. The presence of a huge geriatric population can be taken into consideration as well. The market can also benefit from high per capita income. It can touch a valuation of USD 2,521.3 million by 2023. The US and Canada are countries showing potential to promote this growth for the regional market. The rising healthcare spending in the US, especially for the nonclinical homecare software can provide thrust to the market. The market in the European region is the second largest one and its growth depends on the superlative performance of countries like France, Germany, the UK, and others. These regions are spending significant amount for the development of the healthcare sector, which would also provide traction to the regional market. The Asia Pacific market would witness growth at a substantial scale with major countries like India, China, Japan, and others providing traction for the growth. Its growth would further benefit from revamping healthcare industries in various regions. The Middle East & Africa (MEA) region would find the growth to be sluggish as the lack of financial resource in several countries can bog down the growth of the market.


Nonclinical Homecare Software Market Competitive Landscape:

A number of companies are making changes in their tactical outlook to provide better growth opportunities to the market for nonclinical homecare software. MRFR recorded this change in the market and listed what changes these companies are implementing. This profiling has covered companies like Agfa Healthcare (US), ComForCare Health Care Holdings, Inc. (US), General Electric Company (UK), Mckesson Corporation (US), Allscripts (US), Siemens Healthcare (Germany), Hearst Corporation (US), Cerner Corporation (US), and others.

Acute Care Market Trends, Sales, Supply, Demand, Analysis, Share, Comprehensive Research Study, Emerging Technologies

Acute Care Market Overview

Global acute hospital care market is expected to exhibit a solid 7.8% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). Acute Care Marketis mainly driven by the growing demand for emergency care systems. On the other hand, integration and compatibility issues are likely to be the key restraint for the global acute hospital care market over the forecast period.

Acute Care Market Competitive Analysis:

Leading players in the global acute hospital care market include National HealthCare Corp., PruittHealth, Kindred Healthcare Inc., Ardent Health Services, Vanguard Health System Inc., Tenet Healthcare Corp., Universal Health Services Inc., Community Health Systems LLC, and HCA Holdings Inc.

Leading players are likely to engage in new product development in terms of developing comprehensive acute care suites that can be easily integrated into a hospital’s existing system. Integration issues regarding the acute care system are the main reason for hospitals wanting to replace acute care suites with other services, leading to easy integrability becoming a major topic for manufacturers in the acute hospital care market.

Acute Care Market Segmentation:

The global acute hospital care market is segmented on the basis of medical condition and services.

On the basis of the medical condition, it is segmented into emergency care, urgent care, short-term stabilization, pre-hospital care, critical care, trauma care, and acute care surgery.  

On the basis of the services, it is segmented into coronary care, intensive care, neonatal intensive care, cardiology, and emergency department.

Acute Care Market Regional Analysis:

The global acute hospital care market is likely to be dominated by the Americas sector over the forecast period due to the growing number of patients in the region. The increasing patient demographic as well as the increasing healthcare expenditure in the region are likely to be the major drivers for the acute hospital care market in the Americas region over the forecast period. The North American market is likely to dominate global proceedings, with the US and Canada emerging as leading revenue generators for the acute hospital care market in the region. The widespread availability of advanced healthcare infrastructure in the Americas, and particularly North America, has enabled rapid growth of the acute hospital care market in the region. Advanced first aid services are available in North America at a large range of dispensation points, as well as being home to a number of large hospitals operating widespread networks, leading to easy availability of medical services in cases of emergencies or accidental trauma.

The U.S. is likely to dominate the global acute hospital care market over the forecast period due to the growing demand for acute care facilities in the region’s highly developed hospital infrastructure.


Europe will hold the second largest share in the global acute hospital care market over the forecast period due to the growing healthcare infrastructure put in place by the governments in the region. The strong public healthcare infrastructure in Europe is likely to drive the demand from the acute hospital care market in the region over the forecast period. European consumers are also highly aware of their first responder duties, leading to more cases of accidents or other adverse events being reported and the victims in the case receiving assistance from locals. Developed countries such as Germany, France, and the UK are likely to be the major drivers for the acute hospital care market over the forecast period.

In August 2019, the UK announced a cash boost of GBP 1.8 billion to the NHS, in an effort to redevelop and improve up to 20 hospitals.

Asia Pacific is also likely to remain a highly influential market for the global acute hospital care market, with the region expected to exhibit the fastest growth rate over the forecast period. Increasing healthcare infrastructure development efforts in leading regional economies such as China and India are likely to be a major driver for the acute hospital care market in Asia Pacific over the forecast period.

Kidney Biopsy Device Market by Type, Applications, Growth Drivers, Trends, Demand and Global Forecast To 2023

Kidney Biopsy Device Market Overview

Global kidney biopsy market is expected to exhibit a strong 5.2% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The report uses industry-standard analytical tools and methods to profile the global kidney biopsy market and provide a comprehensive overview of the market’s likely growth trajectory over the forecast period. The leading drivers and restraints operating on the global Kidney Biopsy Device Market are also profiled in the report in order to provide readers with a comprehensive report on the market’s growth trajectory in the coming years. The competitive landscape of the global kidney biopsy market is also explained in the report with the help of company profiles of all the leading players operating in the market.

Kidney biopsy is a surgical operation intended to remove a sample from the kidney for testing. The growing prevalence of chronic kidney disease (CKD) around the world is likely to be a major driver for the global kidney biopsy market over the forecast period. Chronic kidney disease is a serious medical condition and yet doesn’t present with significant symptoms, making it a silent killer. The kidneys are among the most important organs for overall health, and play a crucial role in removing toxins such as urea from the body. Protein digestion is also closely associated with the function of the kidneys, as kidneys digest the leftover proteins and are responsible for removing excess protein left over in the body after digestion. The growing prevalence of high-protein diets has been a key factor responsible for the growth of the kidney biopsy market, as it has been responsible for a significant increase in the prevalence of chronic kidney disease.

The rising need for better diagnostic methods and treatments for kidney diseases is likely to be a major driver for the global kidney biopsy market over the forecast period. Kidney diseases represent a significant burden on the healthcare sector, especially in developing regions, where awareness about them is still lacking and many more people fall prey to them than in developed regions. This is likely to result in developing economies playing a key role in the development of the kidney biopsy market in the coming years. Developments in the process and technology of kidney biopsies are likely to be developed in emerging economies, where the healthcare sector has exhibited steady growth in the recent past. Major players operating in developed economies are likely to be crucial to this transformation, as they currently hold the capacity to carry out kidney biopsies in a safe and efficient manner.

Kidney Biopsy Device Market Competitive Analysis:

Leading players in the global kidney biopsy market include Argon Medical Devices Inc., CareFusion, Focal Therapeutics Inc., Creganna, Integra LifeSciences Corporation, Scion Medical Technologies LLC, Precision Biopsy LLC, Intact Medical Corporation, Hologic Inc., Devicor Medical Products Inc., C. R. Bard Inc., Cook Medical, and Boston Scientific Corporation. Leading players in the global kidney biopsy market are likely to focus on product development and advancement in the coming years.

Kidney Biopsy Device Market Segmentation:

The global kidney biopsy market is segmented on the basis of type, indication, and end user.

On the basis of diagnosis, the kidney biopsy market is segmented into percutaneous biopsy and surgical biopsy.

On the basis of indication, the global kidney biopsy market is segmented into hematuria, kidney failure, proteinuria, kidney transplant, and others.

Based on the end user, the market is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.


Kidney Biopsy Device Market Regional Analysis:

The Americas is the largest regional market in the global kidney biopsy market, followed by Europe. Asia Pacific is expected to exhibit the highest growth rate in the market in the coming years due to the rapid growth of the healthcare sector in the region. Widespread availability of government reimbursement schemes in the Americas and Europe, especially in North America and Western Europe, is also likely to be a major driver for the global kidney biopsy market over the forecast period.

Gastric Bypass Market Latest Innovations, Analysis, Business Opportunities, Overview, Component, Industry Revenue and Forecast

Gastric Bypass Market Analysis

Gastric bypass is one of the vastly studied surgeries that can even benefit offering several positive effects in the treatment of blood pressure, sleep apnea, and certain forms of cancer. This surgery can also impact diabetes treatments and most importantly with a remarkably fast weight reduction.

During various types of research conducted on gastric bypass, a drastic reduction (over 90 percent) in new onset type 2 diabetes was found. Also, in other obesity-related conditions assessed it was found that gastric bypass can bring a significant reduction in the occurrence of high blood pressure and dyslipidemia. Such phenomenal outcomes that the surgery offers are acting as major tailwinds pushing the market on the global platform.

Acknowledging the rapid expansion, the market is witnessing at present, Market Research Future (MRFR) in its recently published study analysis asserts that the global gastric bypass industry would garner exponential accruals by 2023; posting a CAGR of 6.1% throughout the review period (2017 – 2023).  The extensive uptake of gastric bypass surgery is a major factor driving the growth of the market.

Additional factors that are substantiating the growth of the market include the rising prevalence of obesity, diabetes, and cardiovascular disease, leading to increasing the demand for minimally invasive procedures for the treatment. Moreover, increasing adoption of advanced surgical devices across the medical sector is the primary factor fostering the market growth of the market.

On the other hand, factors such as the side effects associated with the gastric bypass surgery such as developing suicidal tendencies are impeding the growth of the market. Nevertheless, factors such as the full-fledged counseling session conducted before and after the surgery to highlight the need for considerable attention to patients’ psychological health, are expected to support the growth of the market, positively influencing the decision for the operation.

Gastric Bypass Market – Segmentations

For ease of understanding, the analysis has been segmented into four key dynamics: 

By Type: Endoscopic Sleeve Gastroplasty and Intragastric Balloon among others.

By Indication: High Blood Pressure, Heart Disease, Type 2 Diabetes, and Gastroesophageal Reflux Disease among others.

By End-user: Clinics and Surgical Centers and Hospitals among others.

By Region : North America, Asia Pacific, Europe, and the Rest-of-the-World. 

Gastric Bypass Market – Geographical Analysis

The North America region, heading with the increasing prevalence of obesity and cardiovascular diseases dominates the global gastric bypass market. Factors that are substantiating the growth in the regional market include the presence of well-established market players & manufacturing setups for the surgical devices and the availability of advanced healthcare specialty services.

The U.S. with its well-developed technology and high healthcare expenditure help the region to command the largest market share. Continuing with the same growth trends, the gastric bypass market in North America is expected to retain its dominance throughout the forecast period.

The gastric bypass market in the European region accounts for the second-largest market, globally. Factors such as the increasing diabetic population and the extensive research & development activities in the field of gastroenterology led by the availability of funds foster the growth in the regional market. Germany and France backed by the increasing use of minimally invasive surgical procedures in hospitals, and surgical centers account for the significant contributors to the growth of the regional market.   

The Asia Pacific gastric bypass is emerging as a profitable market, globally. Factors such as the vast technological developments are acting as key driving forces behind the growth of the regional market, meeting the demand for technologically advanced devices for minimally invasive surgical procedures. The rapidly improving economy in the region is acting as a major tailwind that is impacting the growth in the regional market, positively.

Also, the availability of the low-cost treatment and drugs is facilitating the needed boost to the market growth, meeting the large unmet clinical needs of the vast population. Furthermore, factors such as the increasing occurrences of diabetes and cardiovascular diseases and the rising number of specialty services, provide impetus to the market growth to an extent.

Simultaneously, the growing penetration of healthcare insurance mainly in Thailand, Malaysia, and Vietnam alongside the other South East Asian countries are expected to drive the gastric bypass market in the APAC region. 


Global Gastric Bypass Market – Competitive Analysis

Highly competitive, the gastric bypass market appears fragmented due to the presence of several matured players. These players form a healthy competitive landscape which results in intensifying the completion in the market. Mergers & acquisitions, innovation, and brand reinforcement remain the key trends for leading players.

Gastric Bypass Market Major Players:

Key players leading the global gastric bypass market include Intuitive Surgical Inc. (US), TransEnterix Inc.  (US), Medtronic (US), USGI Medical Inc. (US), Cousin Biotech (France), ALLERGAN (Republic of Ireland), Johnson & Johnson Services, Inc. (US), Mediflex Surgical Product (US), and GI Dynamics Inc. (US) among others.

Rapid Sterility Testing Market Analysis 2020-2023: Key Findings, Regional Analysis, Key Players Profiles And Future Prospects

Rapid Sterility Testing Market Overview:

Global Rapid Sterility Testing Market Report, as opined by Market Research Future (MRFR) in their recently published report, is expected to leap from its Rapid Sterility Testing Market valuation of USD 158 million in 2017 with a CAGR of 13.4% during the forecast period (2018-2023). Rapid sterility testing is known for its prolific ability of microbial contamination detection from a biologic sample. The testing has widespread use in sectors such as pharmaceutical, biotechnology, and medical devices. In quality control of devices, it is used to test for sensitivity and maintain specificity.

Global Rapid Sterility Testing Market is benefiting much from the advanced technological usage of sterility testing such as ATP bioluminescence, colorimetric growth detection, and autofluorescence detection. The rising investment in the research and development of the healthcare sector, along with demands for cutting-edge products from the pharmaceutical sectors are expected to provide substantial thrust to the market. The inclusion of rapid sterility testing helps in fast launching of products and reduce errors in due processes. It is also witnessing several strategic stances being taken by market titans to ease the way towards progress.

On the flip side, the rapid sterility testing market could get hindered by the high product cost and availability of alternative methods can hold back the market growth.

Rapid Sterility Testing Market Segmental Analysis:

MRFR in their report on the global rapid sterility testing market segmented it by product, technology, and application. This segmentation reveals both volume-wise and value-wise growth possibility for a comprehensive understanding of the entire market.

Based on the product, the rapid sterility testing market can be segmented into kits & reagents, instruments, and services. The biological kits & reagents segment has the maximum market share as of 2017 due to its substantial use in research and laboratories.

Based on technology, the rapid sterility testing market comprises membrane filtration, ATP bioluminescence, and other technologies. The ATP bioluminescence segment is helming the overall segment and is gaining significant momentum to profit more during the review period.

Based on the application, the rapid sterility testing market includes pharmaceutical & biological manufacturing, medical device manufacturing, and other end-users. The medical device manufacturing segment is gaining substantial fortune due to the rising demand from the healthcare sector.

Rapid Sterility Testing Market Regional Analysis:

MRFR’s region-specific global rapid sterility testing market analysis includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). The aim is to identify growth pockets to understand regional growth better.

The Americas is expected to dominate the rapid sterility testing market growth. The credit goes to a superior infrastructure that encompasses a robust healthcare infrastructure and strong research and development sector owing to high expenditure capability. Additionally, both pharmaceutical and medical device industry are providing much-needed thrust.

Europe is ranked second, and its features are quite similar to that of the Americas owing to which the regional market is witnessing growth. The APAC market is witnessing rapid growth as several countries such as China, Japan, Republic of Korea, India, Australia have developed a substantially strong healthcare sector. Its growth could surpass others during the forecast period. However, the MEA market is showing some moderate growth owing to its poor infrastructure in healthcare and research & development.

Browse Complete Report with TOC at

Rapid Sterility Testing Market Competitive Landscape:

Influential companies, as recorded in the MRFR report, to boost the global rapid sterility testing industry are Gibraltar Laboratories (US), Charles River Laboratories, Inc. (US), Merck KGaA (Germany), bioMérieux (France), Rapid Micro Biosystems, Inc. (US), Becton, Dickinson, and Company (US), Eurofins Scientific (Luxembourg), Sartorius AG (Germany), FOCUS Laboratories (US), and Thermo Fisher Scientific (US). Strategic decisions and implementations are at the core of the holistic growth of both the company and the market.

Create your website at
Get started